Compare Cassava Sciences Inc (FLNA) vs Quantum Computing Inc (QUBT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Quantum Computing Inc — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Quantum Computing Inc trades at $7.66 (market cap $1.81B). The key difference: Quantum Computing Inc is far larger — about 34.1× Cassava Sciences Inc's market cap. Which is the better fit depends on your goals.
| FLNA | QUBT | |
|---|---|---|
Market Cap | $53.14M | $1.81B |
Sector | Health | Technology |
52-Week High | $4.64 | $24.62 |
52-Week Low | $1.09 | $6.31 |
Enterprise Value | -$33.43M | $830.89M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
Quantum Computing Inc. (QUBT) trades at $7.81, down 6.13% today amid broader quantum stock weakness. The stock shows bearish technical signals with negative moving averages but oversold RSI conditions. Fundamentally, QUBT reports minimal revenue of $682K (2025) with significant losses (-$18.67M net income) and negative margins, though recent earnings beat expectations. Analyst sentiment remains bullish with a $24 consensus target representing 207% upside potential, supported by strategic acquisitions and quantum commercialization progress.
QUBT offers speculative growth potential in quantum computing but carries substantial risk due to heavy cash burn (-$30M operating cash flow) and unproven commercial scalability. The company's survival depends on continued financing and successful technology commercialization. While analyst optimism and policy tailwinds provide catalysts, investors face binary outcomes between breakthrough success and financial distress in this capital-intensive sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Quantum Computing Inc
Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →
